Close
FINDING CURES TOGETHER<sup>SM</sup>

Inaugural AACR International Meeting
Advances in Malignant Lymphoma:
Maximizing the Basic-Translational Interface for Clinical Application

​In cooperation with the International Conference on Malignant Lymphoma (ICML)

June 22-26, 2018
Boston Marriott Copley Place
Boston, Massachusetts

Scientific Committee
Chair: Ari M. Melnick
, Weill Cornell Medical College, New York, New York

Cochairs
Francesco Bertoni,
Intsitute of Oncology Research, Bellinzona, Swizterland
Renier J. Brentjens, Memorial Sloan Kettering Cancer Center, New York, New York
Bertrand Nadel, Centre d'Immunologie de Marseille-Luminy, Marseille, France
Lisa G. Roth, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, New York
Louis M. Staudt, National Cancer Institute, Bethesda, Maryland
Christian Steidl, BC Cancer Agency Vancouver Center, Vancouver, BC, Canada
Karin Tarte, University of Rennes, Rennes, France
Thomas E. Witzig, Mayo Clinic College of Medicine, Rochester, Minnesota
Wei-Li Zhao, Ruijin Hospital, Shanghai Institute of Hematology, Shanghai, China

 

This must-attend program will provide a unique forum for interactive discussion and brainstorming among basic scientists, translational researchers, clinical investigators, hematologists, radiotherapists, pediatric oncologists, pathologists; and computational and systems biologists, and patient-advocates about how recent advances and emerging areas of lymphoma research hold enormous potential for transforming clinical care.

The lymphoma field is advancing rapidly, thanks to the full sequencing of the lymphoma genome, the discovery of new mechanistic data explaining how mutations work, the development of targeted therapies, recognition of “pre-lymphoma” states as potential risk factors, the advent of immunotherapy, and the unique features of immune tumors. One of the primary goals of this meeting is to generate discussion among clinical and laboratory-based thought leaders in the field by the inclusion of panel discussions in each session. We hope that this novel format will be highly interactive and generate productive ideas to be used as reference points for moving the field forward.    

Supporters

The Leukemia & Lymphoma Society
Pharmacyclics (Poster Sessions)

Professional Educational Grants

AbbVie
AstraZeneca
Kite Pharmaceuticals
Novartis
Seattle Genetics

Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available

Download the Call for Abstracts


#AACRlymp18